Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the standard first line treatment for advanced non-small cell lung cancer (NSCLC) with sensitive EGFR mutations. Among NSCLC, giant cell carcinoma of the lung (GCCL) is a rare pathological subtype with poor prognosis, with n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Weng, Shan-Shan, Cao, Ying, Tang, Xiu-Jun, Zhu, Li-Zhen, Tan, Yi-Nuo, Dong, Cai-Xia, Chen, Jia-Qi, Shen, Hong, Yuan, Ying
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421933/
https://ncbi.nlm.nih.gov/pubmed/28445978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15831
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados